Sanara MedTech Inc. (SMTI)
32.32
-0.14 (-0.43%)
At close: Jan 14, 2025, 3:59 PM
32.12
-0.62%
Pre-market Jan 15, 2025, 06:20 AM EST
undefined% (undefined)
| Bid | 31.7 |
| Market Cap | 282.51M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -32.65 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 35.5 |
| Volume | 18,944 |
| Avg. Volume (20D) | 30,463 |
| Open | 32.02 |
| Previous Close | 32.46 |
| Day's Range | 31.85 - 32.81 |
| 52-Week Range | 26.00 - 40.75 |
| Beta | undefined |
About SMTI
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate matur...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 7, 1994
Employees 107
Stock Exchange NASDAQ
Ticker Symbol SMTI
Website https://sanaramedtech.com
Analyst Forecast
According to 2 analyst ratings, the average rating for SMTI stock is "Buy." The 12-month stock price forecast is $47, which is an increase of 45.42% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Sanara MedTech Inc. is scheduled to release its earnings on Mar 24, 2025,
during market hours.
Analysts project revenue of $21.50M, reflecting a 21.54% YoY growth and earnings per share of -0.7, making a 2233.33% increase YoY.
Analysts project revenue of $21.50M, reflecting a 21.54% YoY growth and earnings per share of -0.7, making a 2233.33% increase YoY.
